Experimental pharmacokinetics of fenozan acid and fenoxan in rabbits

被引:0
|
作者
Prokopov A.A. [1 ]
Shukil' L.V. [1 ]
Berlyand A.S. [1 ]
Veselovskaya I.V. [1 ]
机构
[1] Moscow State University of Medicine and Dentistry, Moscow
关键词
Blood Plasma; Potassium Salt; Absolute Bioavailability; Peroral Administration; Presystemic Metabolism;
D O I
10.1007/s11094-006-0047-1
中图分类号
学科分类号
摘要
The experimental pharmacokinetics of the new antioxidant preparations - fenozan acid and fenoxan (potassium salt of fenozan acid) - were studied in rabbits by monitoring the concentration profiles of the drugs in the blood plasma. Upon peroral administration in a single dose of 100 mg/kg, both fenozan acid and fenoxan are rapidly absorbed into the blood, their maximum concentrations peaking within 12 min after administration. The dynamics of the fenozan acid concentration in the blood plasma upon peroral administration was described by a one-compartment pharmacokinetic model, and that upon the intravenous injection, by a two-compartment model. The pharmacokinetic parameters characterizing the distribution and elimination of fenozan acid and fenoxan were close for both peroral administration and intravenous injections. Fenozan acid was slowly eliminated from the rabbit organism, the mean retention times being 11.3 and 11.8 h; the half-elimination times, 8.28 h and 7.68 h; and the stationary distribution volume, 20.8 and 37.5 liter/kg (i.v. versus p.o., respectively), which is indicative of intracell penetration of the drug and its trapping by organs and tissues. The relatively low value (F = 57.8%) of the bioavailability of fenozan acid upon peroral administration is related to a presystemic metabolism of this drug. © 2006 Springer Science+Business Media, Inc.
引用
收藏
页码:5 / 7
页数:2
相关论文
共 50 条
  • [1] SULACILLIN PHARMACOKINETICS IN EXPERIMENTAL RABBITS
    BEDNOVA, VN
    DMITRIYEV, GA
    VASILYEV, MM
    NAVOLOTSKAYA, TI
    MIRZAYEV, MP
    VESTNIK DERMATOLOGII I VENEROLOGII, 1994, (06) : 15 - 17
  • [2] Pharmacokinetics and nephrotoxicity of aristolochic acid in rabbits
    Chen, Shili-Ming
    Fan, Mei-Yu
    Tseng, Chia-Chi
    Ho, Yih
    Hsu, Kuang-Yang
    TOXICON, 2007, 50 (02) : 180 - 188
  • [3] PHARMACOKINETICS AND ELIMINATION OF SALICYLIC-ACID IN RABBITS
    SHORT, CR
    NEFFDAVIS, CA
    HSIEH, LC
    KORITZ, GD
    MALBROUGH, MS
    BARKER, SA
    DAVIS, LE
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1991, 14 (01) : 70 - 77
  • [4] PHYSIOLOGICALLY BASED PHARMACOKINETICS OF VALPROIC ACID IN RABBITS
    ICHIMURA, F
    DEGUCHI, Y
    YOKOGAWA, K
    YAMANA, T
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1985, 27 (01) : 45 - 60
  • [5] PHARMACOKINETICS OF TIAPROFENIC ACID IN NORMAL RABBITS AND RABBITS SUBJECTED TO JOINT IMMOBILIZATION
    MEYERCARRIVE, I
    GRAHAM, GG
    GHOSH, P
    AGENTS AND ACTIONS, 1993, 39 (1-2): : 59 - 68
  • [6] Studying the bioavailability of fenozan acid in various medicinal forms
    Prokopov A.A.
    Shukil' L.V.
    Berlyand A.S.
    Pharmaceutical Chemistry Journal, 2006, 40 (1) : 1 - 4
  • [7] Study on pharmacokinetics of bupivacaine polylactic acid microspheres in rabbits
    Yu, Yuan
    Gao, Shen
    Zhong, Yan-Qiang
    Fu, Qiang
    Wang, Xin-hua
    2002, Chinese Medical Association (37) : 849 - 852
  • [8] Comparison of pharmacokinetics between glycyrrhizin and glycyrrhetic acid in rabbits
    Ching, H
    Hsiu, SL
    Hou, YC
    Chen, CC
    Chao, PDL
    JOURNAL OF FOOD AND DRUG ANALYSIS, 2001, 9 (02) : 67 - 71
  • [9] THE INFLUENCE OF PYRUVIC-ACID ON THE PHARMACOKINETICS OF SULFADIAZINE IN RABBITS
    HSU, KY
    SONG, DJ
    HO, Y
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1995, 16 (03) : 233 - 244
  • [10] PHARMACOKINETICS OF 5-FLUOROURACIL IN RABBITS IN EXPERIMENTAL REGIONAL CHEMOTHERAPY
    KAR, R
    COHEN, RA
    TEREM, TM
    NAHABEDIAN, MY
    WILE, AG
    CANCER RESEARCH, 1986, 46 (09) : 4491 - 4495